Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 92,598 shares, an increase of 440.2% from the September 30th total of 17,142 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average trading volume of 72,016 shares, the days-to-cover ratio is currently 1.3 days.
Izotropic Stock Up 0.3%
Shares of OTCMKTS:IZOZF traded up $0.00 on Thursday, hitting $0.10. The stock had a trading volume of 42,774 shares, compared to its average volume of 24,225. The firm’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.17. Izotropic has a twelve month low of $0.10 and a twelve month high of $0.34.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last announced its earnings results on Monday, September 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Equities research analysts predict that Izotropic will post 0.03 earnings per share for the current fiscal year.
About Izotropic
Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography.
The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.
Recommended Stories
- Five stocks we like better than Izotropic
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
- Constellation Energy’s Nuclear Expansion Gets a $5 Billion Opening, Not a Guarantee
- Plugging In: Vertiv Cashes In On AI Demand
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
